# Incepto Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/incepto-medical

- Industry: Healthcare IT
- Headquarters: Paris, France
- Website: www.incepto-medical.com
- Total disclosed funding: $31M
- Latest round: Series B (Sep 19, 2022)
- Investors on record: 5

## About

Founded in 2018 and headquartered in Paris, France, Incepto Medical SAS develops medical imaging software and artificial intelligence solutions for healthcare applications. The company was co founded by Antoine Jomier(CEO) and Florence Moreau(CTO) . In September 2026, the company raised USD 16 million in venture funding led by Impactivist, with participation from LBO France, Karista, Bpifrance Investissement, and Wille Finance.

Incepto Medical specializes in developing innovative medical imaging solutions designed to enhance diagnostic accuracy and efficiency for healthcare providers. Their core offerings include advanced software platforms that utilize artificial intelligence to improve the interpretation of medical images, streamlining workflows for radiologists and clinicians. The solutions address critical use cases such as early detection of diseases, improved treatment planning, and reduced diagnostic errors, catering to hospitals, radiology practices, and healthcare networks across Europe and North America, particularly in France, Germany, and the United States. Continuous updates and enhancements keep the products aligned with technological advancements and user feedback.

Incepto Medical generates revenue through a combination of subscription models and partnerships with healthcare institutions. Clients engage in direct transactions for software licenses or annual subscriptions that provide ongoing access to updates and support services. The pricing structure is tiered, allowing healthcare providers to select plans based on their specific needs and deployment scale. Flagship offerings include proprietary software tailored for specific imaging modalities, ensuring they meet end-user demands across diverse clinical settings, facilitating a steady revenue stream while fostering long-term relationships with healthcare providers.

The company will use the September 2026 funding to advance its medical imaging and artificial intelligence platform and strengthen its societal impact initiatives.

## Funding rounds

- Series B, Sep 19, 2022, $27M — LBO France, Karista, Bpifrance Investissement, AXA Venture Partners, Wille Finance
- Series A, Oct 25, 2019, $3.8M — Karista, Bpifrance Investissement, AXA Venture Partners

## Investors

- Karista (https://capitalatlas.ai/funds/karista) — Series A, Series B
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Series A, Series B
- AXA Venture Partners (https://capitalatlas.ai/funds/axa-venture-partners) — Series A, Series B
- LBO France (https://capitalatlas.ai/funds/lbo-france) — Series B
- Wille Finance — Series B